Antonio Escartín

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity

Mariana López‐Góngora, Luís Querol, Antonio Escartín · BMC Neurology · 2015 · 118 citations · Full text

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

María Sepúlveda, Marta Aldea, Domingo Escudero et al. · Multiple Sclerosis Journal · 2017 · 98 citations

Arterial line filtration during cardiopulmonary bypass

Alejandro Arís, Heriberto Solanes, María Luisa Cámara et al. · Journal of Thoracic and Cardiovascular Surgery · 1986 · 66 citations

Blood Flow Measurement, Vascular Surgery, Surgery +5

Prospective Study of New-Onset Seizures in Patients With Human Immunodeficiency Virus Infection

Berta Pascual‐Sedano, A. Iranzo, Joan Martí‐Fàbregas et al. · Archives of Neurology · 1999 · 65 citations